Clinical Trial

Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder

Study acronym: VA-StARTS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to establish a new treatment (repetitive transcranial stimulation (rTMS)) for Veterans with stimulant use disorder (SUD). Despite the large public health burden imposed by SUD, there is currently no FDA-approved or widely recognized effective somatic treatment. This placebo controlled study will test the effectiveness of rTMS in the treatment of SUD, and explore biomarkers that may guide patient selection for rTMS treatment and predict treatment response.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-05.
Trial Details
NCT Number NCT07112105
Lead Sponsor VA Office of Research and Development
Collaborators: Stanford University
Conditions Stimulant Use Disorder
Enrollment 106 participants
Start Date 2026-05-01
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-02